Mr. Stephen O’ Connell (Australia)

Educator/Musician/Composer

Partnerships Liaison at Murray Conservatorium - advocacy for the advancement of Music Education and the delivery of inspirational workshops and concerts

Stephen is a committed music educator and professional musician who has dedicated his life to promoting the benefits of music to everyone in our community. In 2017, Stephen received an OAM for services to the performing arts. As a professional musician, Stephen writes, performs and records music known as "New Standards". Currently, Stephen is writing for string quartet and orchestra as well as jazz bands. This project is known as "SOQ Collective". His primary collaborator is Graham Sattler. As a music educator, Stephen has devoted the last 15 years to working in regional conservatoriums. He was Director at the Goulburn Regional Conservatorium (11 years) and is presently CEO of the Murray Conservatorium in Albury Wodonga. He was the founding President (2003) of the Association of NSW Regional Conservatoriums (ANSWRC ), a position that he currently holds. In 2008, Stephen led a NSW Government review into the status of Music Education in Regional NSW, resulting in an increase of recurrent funding to the program of $2.1M. Stephen in also committed to furthering all art forms in our community, collaborating regularly on projects with visual artists, actors and film makers to create original art. In 2012, and in partnership with Jenny O'Hara, Stephen formed "Kick Up The Arts" (KUTA), a group dedicated to lobbying government to properly fund arts activities from grass roots level all the way to flagship organisations.
Experience

Partnerships Liaison
Company Name: Murray Conservatorium Full-time
Dates Employed: Oct 2020 – Present
Employment Duration: 6 months
Location: Albury, New South Wales, Australia
I advocate for the advancement of Music Education in NSW and deliver inspirational workshops and concerts.

Advocate
Company Name: Parliament of NSW
Dates Employed: Apr 2019 – Oct 2020
Employment Duration: 1 yr 7 mos

CEO
Company Name: Murray Conservatorium
Dates Employed: Jan 2010 – Apr 2019
Employment Duration: 9 yrs 4 mos
Location: Albury, Australia

President, Association of NSW Regional Conservatoriums
Company Name: Association NSW Regional Conservatoriums
Dates Employed: 2003 – Oct 2016
Employment Duration: 13 yrs
The ANSWRC is the peak body for NSW Regional Conservatoriums. It commenced as an Association in 2003 and represents the interests of over 20,000 students and 500 music professionals. Regional Conservatoriums are unique to NSW and are partially funded by the NSW Department of Education and Communities.

Director
Company Name: Goulburn Regional Conservatorium
Dates Employed: Jan 1999 – Jan 2010
Employment Duration: 11 yrs 1 mo

Education
University of NSW
Degree Name: Music Education
Field Of Study: Music
Dates attended or expected graduation: 1980 – 1983
East Hills Boys High School
Degree Name: HSC
Dates attended or expected graduation: 1974 – 1979

Volunteer experience
Club Member
Company Name: Rotary Club of Albury Hume
Cause: Social Services

Dr. Michael W. Hodin (USA)

CEO of Global Coalition on Ageing

Executive Director, Global Coalition on Aging

Adjunct Senior Fellow, Council on Foreign Relations

Managing Director, High Lantern Group

New York, USA

Michael W. Hodin, Ph.D. is the CEO of the Global Coalition on Aging, the leading business voice on aging policy and strategy, aimed at reshaping how global leaders approach and prepare for the 21st century's profound shift in population aging. Mike is also a Managing Partner at High Lantern Group a strategic communications firm.

Prior to founding the Global Coalition on Aging and High Lantern Group, Mike was a senior executive at Pfizer, Inc. for 30 years, where he created and then led its International Public Affairs and Public Policy operations. Prior to joining Pfizer, Mike was Legislative Assistant to Senator Daniel Patrick Moynihan and also a Visiting Scholar at Brookings Institution on U.S. Foreign Economic Policy.

Mike is a Member of the Council on Foreign Relations, and from 2010-2012, was an Adjunct Senior Fellow. He sits on the Boards of the Foreign Policy Association, the Business Council for International Understanding, The NYC Blood Center, the American Skin Association, the American Society on Aging, Harris Manchester College at Oxford University, Emigrant Savings Bank, and on the World Economic Forum's Global Agenda Council for Population Ageing.

Mike holds a BA, cum laude, from Cornell University, M.Sc.in International Relations from The London School of Economics and Political Science, and M.Phil and Ph.D. in Political Science from Columbia University.

Education

• Columbia University in the City of New York, PhD, Political Science
• Cornell University, BA
• London School of Economics and Political Science, MSc, International Relations

Dr Anupama Roy Chowdhury (Singapore)

Consultant Geriatrician at Sengkang General Hospital

Senior Consultant at SingHealth Duke-NUS Centre of Memory and Cognitive Disorders
Senior Consultant in Geriatric Medicine at Sengkang General Hospital
Senior Consultant in Department of General Medicine at Sengkang General Hospital

Dr Anupama Roy Chowdhury is a Senior Consultant with Sengkang General Hospital. She received her medical degree from the National University of Singapore in 2002. She completed her specialist training in geriatric medicine in 2010 and went on to do a fellowship in dementia and neurocognitive disorders at the University of British Columbia, Vancouver in 2013. She has a special interest in dementia, geriatric oncology and medical education. She has previously been secretary and then vice-president of Society of Geriatric Medicine Singapore (SGMS).

Education

● MBBS (Singapore)
● MRCS A&E (UK)
● MRCP(UK)
● Specialist Accreditation in Geriatric Medicine, Singapore
● Fellowship in Neurocognitive Disorders, University of British Columbia, Vancouver
Professional Appointments and Committee Memberships
● Clinical Senior Lecturer, Dept of Medicine, NUS Yong Loo Lin School of Medicine
● Adjunct Faculty, Duke-NUS
● Member, FAMS
● Committee Member, Society of Geriatric Medicine Singapore

Awards
● Fellowship in Neurocognitive Disorders, UBC, Vancouver, HMDP, 2013
Publications
● A rare case of multifocal papillary thyroid cancer in bilateral thyroid cysts - a case report. Roy Chowdhury A, Jack Kian Chng and Choon Chieh Tan. Case Reports in Medicine Volume 2018, Article ID 1656831.
● Neurobehavioural characterization of adult-onset Alexander disease - A family study. Maya L Lichtenstein, MD, MHSc; Emily Dwosh, MSc; Anupama Roy Chowdhury, MBBS, MRCP, FAMS; Matthew J Farrer, PhD; Marna B. McKenzie, BSc; Ilaria Guella, PhD; Daniel M. Evans, BSc; Haakon B. Nygaard, MD, PhD; Jason R Shewchuk, MD; Sherri Hayden, PhD; Jason J.S. Barton, MD, PhD; Howard H. Feldman, MD. Neurology: Clinical Practice Mar 2017, 10.1212/CPJ.0000000000000356.
● Evaluation of unplanned dialysis as a predictor of mortality in elderly dialysis patients: a retrospective data analysis. Roy D, Chowdhury AR, Pande S, Kan JW. BMC Nephrol. 2017 Dec 19;18(1):364. doi: 10.1186/s12882-017-0778-0.
● Comprehensive Geriatric Assessment (CGA) based risk factors for increased caregiver burden among elderly Asian patients with cancer. Rajasekaran T, Tan T, Ong WS, Koo KN, Chan L, Poon D, Roy Chowdhury A, Krishna L, Kanesvaran R. J Geriatr Oncol. 2016 May;7(3):211-8. doi:10.1016/j.jgo.2016.03.003. Epub 2016 Apr 7.
● Practice pearls in the management of lung cancer in the elderly. Kanesvaran R, Row Chowdhury A, Krishna L. J Geriatr Oncol. 2016 Jun 3. pii:S1879-4068(16)30055-8. doi:10.1016/j.jgo.2016.05.004. Review.

Associate Professor Dr Ravindran Kanesvaran (Singapore)

Senior Consultant, Division of Medical Oncology at National Cancer Center

Dr Ravindran Kanesvaran is a Senior Consultant/Deputy Head in the Division of Medical Oncology of the National Cancer Centre Singapore. He is also an Associate Professor at Duke-NUS Medical School and clinical senior lecturer at the Yong Loo Lin School of Medicine, National University of Singapore. He is actively involved in graduate medical education and is a core faculty member of the Medical Oncology Senior Residency Program and the Singhealth Internal Medicine Residency Program.He completed his medical oncology speciality training in the National Cancer Centre Singapore. After completion of that training he followed up with a fellowship in genitourinary oncology (GU) and geriatric oncology in Duke Cancer Institute in North Carolina, USA on a Healthcare Manpower Development Program (HMDP) scholarship awarded by the Ministry of Health Singapore. His research interests include GU oncology and geriatric oncology. He has published in a number of well-known peer reviewed journals including Journal of Clinical Oncology and Lancet Oncology.

He has also been awarded a number of awards including the American Society of Clinical Oncology (ASCO GU) Merit Award 2009, American Association for Cancer Research (AACR) scholar-in-training Award 2010 and European Society of Medical Oncology (ESMO) fellowship award 2012. He is currently the President of the Singapore Society of Oncology (SSO) and the Singapore Geriatric Oncology Society. He has been appointed as European Society of Medical Oncology (ESMO) Faculty 2015-2016. He is on the Scientific and Education Committee and the National Representative for Singapore in the International Society of Geriatric Oncology (SIOG). He was awarded National Representative of the Year SIOG 2014 award.
Education

● FAMS (Med Oncol)
● M.R.C.P. (UK)
● Doctor of Medicine (MD)
● Bachelor of Medical Sciences (Hons)

Professional Appointments and Committee Memberships
● Senior Consultant, National Cancer Centre Singapore
● Clinical Senior Lecturer, Yong Loo Lin School of Medicine, National University of Singapore
● Associate Professor, Duke-NUS Medical School
● Visiting Consultant , Changi General Hospital ( CGH)
● Code Blue Committee 2012- to 2017

Awards
● Journal of Geriatric Oncology Reviewer of the Year Award 2014
● Singapore Health Quality Service Award 2015 (Best Team Award)
● International Society of Geriatric Oncology (SIOG) National Representative of the Year 2014 Award
● Singhealth Outstanding Faculty Award (Academic Year 2013/2014)
● European Society of Medical Oncology (ESMO) Fellowship Award 2012

Publications

● Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients. Marvalim C, Wong JX, Sutiman N, Lim WT, Tan SW, Kanesvaran R, Ng QS, Jain A, Ang MK, Tan WL, Toh CK, Tan EH, Chowbay B. Pharmacogenet Genomics. 2017 Jan 2. doi: 10.1097/FPC.0000000000000266. [Epub ahead of print]
● Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Wells JC, Stukalin I, Norton C, Srinivas S, Lee JL, Donskov F, Bjarnason GA, Yamamoto H, Beuselinck B, Rini BI, Knox JJ, Agarwal N, Ernst DS, Pal SK, Wood LA, Bamias A, Alva AS, Kanesvaran R, Choueiri TK, Heng DY. Eur Urol. 2017 Feb;71(2):204-209.
● Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Choudhury Y, Toh YC, Xing J, Qu Y, Poh J, Huan L, Tan HS, Kanesvaran R, Yu H, Tan MH. Sci Rep. 2017 Jan 25;7:41238. doi: 10.1038/srep41238
● Cultural influences upon advance care planning in a family-centric society.Tay K, Yu Lee RJ, Sim SW, Menon S, Kanesvaran R, Radha Krishna LK. Palliat Support Care. 2017 Feb 8:1-10. doi: 10.1017/S1478951516001139. [Epub ahead of print] PMID: 28173885
● Discontinuing VEGF-Targeted Therapy (VEGF-TT) for progression versus toxicity impacts outcomes of second line therapies in metastatic Renal Cell Carcinoma (mRCC).IMDC , R Kanesvaran, et al. Clin Genitourin Cancer. 2017 (in press)

Research Trials
● A Phase III, Multicenter, Randomized, Placebo-controlled Study of Atezolizumab (Anti-PD-L1 Antibody) as Monotherapy and in Combination with Platinum-based Chemotherapy in Patients with Untreated Locally Advanced or Metastatic Urothelial Carcinoma (WO30070), 2017
● A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination with Bevacizumab versus Sunitinib in Patients with Untreated Advanced Renal Cell Carcinoma (WO29637), 2016
● AR-V7 Splice Variant in Asian Patients with Castration-Resistant Prostate Cancer (CRPC), 2015
● A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced/Unresectable or Metastatic Urothelial Cancer (MK 3475-052), 2015
● A Phase III Randomized Trial of Pembrolizumab (MK-3475) versus Paclitaxel or Vinflunine in Subjects with Recurrent or Progressive Metastatic Urothelial Cancer (MK3475-045), 2015